Sanofi slashes US prices through its Insulins Valyou Savings Program

Effective July 1, uninsured people living with diabetes in the USA be able to obtain one or multiple Sanofi (Euronext: SAN) insulins from the French pharma major’s  Insulins Valyou Savings Program with a valid prescription for a total of $35 for a 30-day supply. Previously, the program offered a 30-day supply of Sanofi insulins for $99.

Adam Gluck, head of US and global specialty care corporate affairs, Sanofi, commented: “Informed by patient feedback, Sanofi has updated our industry-leading assistance program to continue addressing access and affordability challenges for all people living with diabetes, regardless of insurance coverage. This is yet another example of our determination to partner with the patient community and meet our commitment to ensure every patient can access and afford the insulin they need.

Sanofi believes that people living with diabetes should not face high out-of-pocket costs at the pharmacy counter. Individuals can access the program regardless of income level. In 2021, the Insulins Valyou Savings Program was used more than 97,000 times and provided more than $37 million in savings to people living with diabetes.